Gsa Capital Partners LLP Greenwich Life Sciences, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023
BUY
$8.41 - $10.66 $104,628 - $132,621
12,441 Added 37.24%
45,850 $405,000
Q2 2023

Aug 14, 2023
BUY
$9.58 - $13.2 $198,794 - $273,913
20,751 Added 163.94%
33,409 $322,000
Q1 2023

May 12, 2023
SELL
$12.12 - $20.8 $1,454 - $2,496
-120 Reduced 0.94%
12,658 $174,000
Q4 2022

Feb 13, 2023
BUY
$9.04 - $16.88 $115,513 - $215,692
12,778 New
12,778 $194,000

Others Institutions Holding GLSI

# of Institutions
38
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About Greenwich LifeSciences, Inc.

GLSI Quotes by TradingView
  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $158M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email